CEO of $CRUS sells 21,806 shares in insider sale

The CEO of $CRUS, John Forsyth, recently made a significant move by selling 21,806 shares of the company, totaling an estimated $2,947,080. This transaction, disclosed in a recent SEC filing, represented about 30.1% of Forsyth’s shares of this stock class, leaving him with 50,723 shares in this category.

Tracking $CRUS insider trading activity reveals that company insiders have engaged in 15 transactions on the open market within the last 6 months, with all 15 being sales and zero purchases. Apart from Forsyth, executives like Jeffrey W Baumgartner, Scott Thomas, Andrew Brannan, Denise Grode, Carl Jackson Alberty, and Justin E Dougherty have also made significant sales of company shares during this period.

Institutional investors have also been active in adjusting their holdings of $CRUS stock in recent quarters, with 242 investors adding shares to their portfolio and 253 reducing their positions. Major moves have been observed from firms like Ameriprise Financial Inc, Acadian Asset Management LLC, and Vaughan Nelson Investment Management, L.P., among others, demonstrating shifts in their investment strategies concerning $CRUS stock.

In terms of revenue, $CRUS reported revenues of $580.6M in the third quarter of 2026, which marked a 4.48% increase compared to the same period the previous year. This positive revenue growth indicates the company’s financial health and performance.

Wall Street analysts have also been closely monitoring $CRUS, with four firms issuing buy ratings on the stock in recent months. These ratings suggest confidence in the company and its future prospects, with analysts from Benchmark, Stifel, Keybanc, and Susquehanna specifically highlighting positive expectations for $CRUS.

Moreover, analysts have set price targets for $CRUS, with a median target of $155.0 based on recent assessments. Notable analysts like Tore Svanberg, David Williams, Tom O’Malley, John Vinh, and Christopher Rolland have provided insights into the valuation of $CRUS stock, indicating varying but optimistic price targets for potential investors.

It is essential to note that this article serves to provide information on recent insider activity, hedge fund movements, revenue growth, analyst ratings, and price targets concerning $CRUS, but it is not intended as financial advice. Readers interested in further details should refer to Quiver Quantitative’s platforms for comprehensive data on $CRUS stock performance and related financial metrics.